𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term effects of the treatment of polycythemia vera with recombinant interferon-α

✍ Scribed by Richard T. Silver

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
143 KB
Volume
107
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LONG-TERM CONTROL OF POLYCYTHEMIA RUBRA
LONG-TERM CONTROL OF POLYCYTHEMIA RUBRA VERA WITH RECOMBINANT ALPHA INTERFERON
✍ M. J. CLEMONS; Y. F. WILLIAMS; J. M. GOLDMAN; A. J. BARRETT 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

The natural history of PRV is characterized by a prolonged period of myeloproliferation chiefly affecting the red cell series. It can be controlled by venesection and cytotoxic agents. In this case report the patient declined further 'standard' chemotherapy to control his disease and the use of rela

Relief of intractable pruritus in polycy
Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa
✍ Dr. Carlo Finelli; Luigi Gugliotta; Barbara Gamberi; Nicola Vianelli; Giuseppe V 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 2 views

Following reports that recombinant interferon alfa (rlFNu), besides inducing clinical and hematologic remission in polycythemia Vera (PV), can also resolve intractable pruritus, we used rlFNu to treat 13 PV patients complaining of severe pruritus refractory to conventional treatment (venesection and

Role of interferon alpha-2a in the treat
Role of interferon alpha-2a in the treatment of polycythemia vera
✍ Paolo Foa; Paolo Massaro; Sonia Ribera; Alessandra Lurlo; Carmen Mezzanotte; Dan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB 👁 2 views

We studied the effects of recombinant interferon alpha-2a (IFN-alpha) in 36 patients with polycythemia Vera (PV) previously treated with phlebotomy and/or conventional cytostatic agents. In each patient, after at least 2 months of discontinuation of any cytotoxic therapy, the hematocrit (Hmt) was fi

Polycythemia vera treated with recombina
Polycythemia vera treated with recombinant interferon-alpha 2a: Evidence of a selective effect on the malignant clone
✍ Massaro, Paolo; Foa, Paolo; Pomati, Mauro; LaTargia, Maria Luisa; Iurlo, Alessan 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 15 KB 👁 2 views

We periodically analyzed bone-marrow cytogenetic features in 8 patients belonging to a series of 38 subjects with polycythemia vera (PV), all treated with recombinant interferonalpha 2a (rIFN-alpha) at a weekly dose of 9,000,000 IU. Six out of these 8 patients never showed any chromosome alterations

Long term treatment of myeloproliferativ
Long term treatment of myeloproliferative disease with interferon-α-2b : Feasibility and efficacy
✍ Harriet S. Gilbert 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## BACKGROUND. Recombinant interferon-␣-2b (rIFN-␣-2b) has shown therapeutic potential in patients with chronic myelogenous leukemia and other myeloproliferative disorders (MPDs), including the ability to suppress the abnormal hematopoietic clone and to reverse myelofibrosis. This study was conduc